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Background: Hepatitis C virus (HCV) infection may cause liver diseases of various severities ranging from primary
acute infection to life-threatening diseases, such as cirrhosis or hepatocellular carcinoma with poor prognosis.
According to clinical findings, HCV infection may also lead to some extra-hepatic symptoms, including type 2
diabetes mellitus (DM). Since insulin resistance is the major etiology for type 2 DM and numerous evidences
showed that HCV infection associated with insulin resistance, the involvement of E2 in the pathogenesis of type 2
DM and underlying mechanisms were investigated in this study.
Methods: Reverse transcription and real-time PCR, Western blot assay, Immunoprecipitation, Glucose uptake assay
and analysis of cellular glycogen content.
Results: Results showed that E2 influenced on protein levels of insulin receptor substrate-1 (IRS-1) and impaired
insulin-induced Ser308 phosphorylation of Akt/PKB and Ser9 phosphorylation of GSK3β in Huh7 cells, leading to an
inhibition of glucose uptake and glycogen synthesis, respectively, and eventually insulin resistance.
Conclusions: Therefore, HCV E2 protein indeed involved in the pathogenesis of type 2 DM by inducing insulin
resistance.
Keywords: Hepatitis C virus, E2 envelope protein, Type 2 diabetes mellitus, Insulin resistance, Insulin receptor
substrate-1 (IRS-1), GSK3βBackground
An infection of hepatitis C virus may lead to serious
liver diseases including chronic hepatitis, cirrhosis and
hepatocellular carcinoma with poor prognosis [1-4].
HCV is an enveloped virus with a single-stranded
positive-sense RNA genome of about 9.6 kb encoding 10
different proteins, including 3 structural proteins core,
E1, E2 and 7 nonstructural proteins p7, NS2, NS3,
NS4A, NS4B, NS5A and NS5B [5-7].
Besides causing liver diseases, HCV may lead to some
extra-hepatic complications including type 2 diabetes
mellitus (T2DM) [8] based on some epidemiological* Correspondence: cshy042@csh.org.tw; hlchiou@csmu.edu.tw
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reproduction in any medium, provided the orevidences. Furthermore, regardless of cirrhosis, the preva-
lence of T2DM of patients with HCV infection was much
higher than that of patients with HBV infection [9-11]. It
clearly indicated that HCV may somehow involve in the
pathogenesis of T2DM, which causes hyperglycemia that
involving multiple factors, especially insulin resistance
[12]. Individuals with insulin resistance may produce suffi-
cient insulin, but can’t effectively reduce blood sugar level
because of resisting the function of the insulin, which
mainly involves an impairment of insulin signaling path-
way. Insulin receptor (IR) is a receptor with tyrosine kin-
ase located on plasma membrane which contains two
subunits, α and β subunits [13,14]. The tyrosine residues
of IRS-1 also can be phosphorylated to turn on the insulin
signaling pathway. The phosphorylated IRS-1 actives
phosphatidylinositol 3-kinase (PI3K) that promote Phos-
phatidylinositol 4, 5-bisphosphate (PIP2) conversion intotd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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leads to Akt/PKB (protein kinase B) undergoes serine/
threonine phosphorylation at the residues of Ser473 and
Thr308 [15,16]. Finally, it promotes glucose transporter-4
(GLUT-4) translocation to plasma membrane to enhance
glucose uptake [17,18]. According to the mechanism of in-
sulin resistance, impairment of activation of Akt/PKB or
GSK3 is the key role which can inhibit glucose uptake or
glycogen synthesis, respectively.
Evidences indicated that cells expressing HCV proteins
possess impaired insulin signaling [19]. Among HCV
proteins, core protein was the most investigated target
with extensive data accumulated during recent years
[20-22]. Studies suggested that core protein might in-
hibit insulin signaling through increasing the expression
of suppressors of cytokine signaling 3 (SOCS3) [20] or
upregulating serine phosphorylation of IRS-1 by activa-
tion of c-Jun N-terminal kinase (JNK) [21]. The result-
ant event is the impairment of IRS-1 function and the
downstream signaling. Such core protein-related
mechanisms seem genotype-specific [22]. However, the
involvement of HCV proteins other than core protein
have not been investigated. Among them, E2 is mainly
responsible for viral entry and plays an important role
for virus infection. Nevertheless, the involvement of E2
in type 2 DM has not been investigated. Some evidences
suggested HCV E2 protein could activate extracellular
signal-regulated kinase (ERK) signaling which interact
with cell surface CD81 [23-25]. ERK is one of the IRS-1
kinases which can upregulate serine phosphorylation of
IRS-1 following an inhibition of IRS-1 function and
eventually leading to insulin resistance [26]. Therefore,
this study was conducted to understand the ability of
HCV E2 for the induction of insulin resistance and the




Human recombinant insulin was purchased from Roche.
SOCS3 antibody was from Santa Cruz Biotechnology.
IRS-1, insulin receptor-beta (IRβ), phosphor-Akt
(Ser473), ubiquitin, GSK3β and phosphor-GSK3β (Ser9)
antibodies were from Cell Signaling Technology.
phosphor-Akt (Thr308) antibodies was from Novus Bio-
logical. Akt/PKB and β-actin antibodies were from BD
Biosciences. HCV E2 protein genotype 1b antibody was
from Abcam. Peroxidase-conjugated goat anti-rabbit and
goat anti-mouse secondary antibodies were from Jackson
Immunoresearch Laboratories.
Cell culture and transfection
Huh7, a human hepatoma cell line, obtained from the
Food Industry Research and Development Institute(Hsinchu, Taiwan), were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) (Gibco BRL, Grand Island, NY,
USA) supplemented with 10% fetal calf serum (FCS),
1 mM glutamine, 1% penicillin/streptomycin, 1.5 g/L so-
dium bicarbonate, and 1 mM sodium pyruvate (Sigma, St.
Louis, Mo, USA). For transfection, 2 × 105 cells were
seeded on a culture dish of 6 cm on the day prior to trans-
fection and then transfected with FLAG-CMV2 or FLAG-
E2 plasmid [27] using TurboFectTM in vitro transfection
reagent (Fermentas Life Sciences) according to the manu-
facturer’s instructions. After an overnight incubation, west-
ern blot was conducted to detect E2 protein level to
ensure the successful expression. For insulin stimulation,
cells were incubated with serum-free DMEM for 16 hours
followed by a treatment with 100 nM insulin for an indi-
cated time.
Reverse transcription and real-time PCR
Total cellular RNA was extracted using TriSolution
(GeneMark) and phenol/chloroform method. After being
precipitated with isopropanol, 2 μg of total cellular RNAs
were subjected to cDNA synthesis by MMLV reverse
transcriptase (Promega) and oligo-dT primer according
to the manufacturer’s instructions. For the quantification
of human IRS-1 (Hs00178563_m1), real-time PCR with
TaqManW Fast Universal PCR Master Mix and TaqManW
specific primer with MGB probe (all from Applied Bio-
systems) were conducted with a normalization with
human GAPDH (Hs99999905_m1). Real-time PCR was
also conducted for insulin receptor (IR) with FastStrat
Universal SYBR Green Master (Roche) and primers (for-
ward 5′-CGGCCAGAGGCTGAGAATAAT-3′, reverse
5′-CGCCATCTGAATCA TCTCTTGA-3). All real-time
PCR assays were performed on StepOneTM Real-Time
PCR System (Applied Biosystems) and the Ct value was
analyzed by StepOneTM Software v2.0.
Western blot assay
Cells were harvested and lysed using RIPA buffer (50 mM
Tris–HCl pH8.0, 0.1% SDS, 1% NP40, 150 mM NaCl, 20%
glycerol, 2 mM dithothreitol, 0.5% deoxycholate acid) con-
taining protease inhibitors and phosphates inhibitors. The
cell lysates were separated in polyacrylamide gels and
transferred onto polyinylidene fluoride membrane. After-
wards, membranes were incubated with blocking buffer
(5% non-fat milk in TBST (TBS buffer with 0.1% Tween-
20)) for 1 hour, and incubated with specific primary anti-
body overnight in 4 °C. After washing with TBST for 3
times, members were incubated with an appropriate
peroxidase-conjugated secondary antibody for 1 hour in
room temperature followed by TBST washing for 3 times.
Signal was developed by chemiluminescent HRP substrate
(Millipore) and detected by LAS-1000 Luminescent Image
Analyzer (FUJIFILN). Relative photographic density was
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gel documentation and analysis system (Alpha Imager
2000, Alpha Innotech Corporation).
Immunoprecipitation
E2-transfected and un-transfected Huh7 cells were lysed
on ice for 20 minutes in RIPA buffer. After centrifuga-
tion, supernatant was incubated with IRS-1 antibody at
4 °C for overnight, followed by incubation with protein
A/G-PLUS-agarose at 4 °C for 1 hour. Immunocom-
plexes were washed After being washed for 3 times in
RIPA buffer, the reaction was terminated by adding 5×
SDS sample buffer and then subjected to western
analysis.
Glucose uptake assay
Cells cultured in 24-well plates were deprived of serum
by incubation in serum-free medium for 16 hours. The
cells were then washed with KRH (−) glucose (12 mM
Hepes, 121 mM NaCl, 4.9 mM KCl, 1.2 mM MgSO4,
0.33 mM CaCl2, pH 7.4). In brief, cells were initiated by
addition 225 μL of working solution of insulin in KRH
(−) glucose into each well for 13 minutes. At the end of
incubation, 1.25 μL of cytochalasin B stock solution was
added into wells while 1.25 μL of 100% DMSO was
added to other wells followed by a gentle shaking for 2
minutes. Glucose uptake was initiated by an addition of
25 μl of reaction solution (KRH (−) containing 0.04 mM,
2-deoxy-D-[1,2-3H] glucose) to each well. After 5 min-
utes, transport was terminated by washing the cells with
ice-cold KRH (+) glucose (KRH (−) glucose containing
25 mM D-(+)-Glucose). The cells were solubilized by
0.1% sodium dodecyl sulfate, and the incorporated radio-
activity was measured by liquid scintillation counter.
Analysis of cellular glycogen content
To measure the content of glycogen, Huh7 cells were
seeded at a density of 2 × 105 cells/dish. After an over-
night incubation, cells were transfected with or without
HCV E2 expression plasmid. After being cultured in
serum-free medium overnight, cells were cultured in
DMEM containing 100 nM insulin for 9 hours. Cells
were washed to remove extracellular glucose and homo-
genized with 200 μl dH2O on ice. Homogenates were
boiled for 5 minutes and spin at 13000 rpm for 5
minutes. The final supernatant was then subjected to
glycogen assay kit (Biovision).
Statistical analysis
Statistical significances of difference throughout this
study were calculated by One-Way ANOVA test using
SPSS software. P value less than 0.05 was regarded as
statistically significant.Result
HCV E2 expression had an influence on IRS-1 protein level
Upon the stimulation of insulin, activation of IR and
IRS-1 are the first key steps for glucose metabolisms. An
altered IR expression or tyrosine phosphorylation will
lead to insulin resistance [28,29]. Therefore, the impact
of HCV E2 protein on IR or IRS-1 expression was inves-
tigated. After a transfection of FLAG-E2 expression
plasmid RT-PCR and western blot assays were con-
ducted to ensure a successful expression of E2 protein in
Huh7 cells (Figure 1A). Then, IR and IRS-1 expression
levels were detected by semi-quantitative RT-PCR, real-
time RT-PCR and western blot. Results of real-time RT-
PCR suggested that HCV E2 protein has no influence on
mRNA levels of IR and IRS-1 (Figure 1B, 1C, 1D). How-
ever, IRS-1 protein level was significantly reduced
responding to the expression of HCV E2, as shown by
results of western blot (Figure 2).
The expression levels of SOCS3 is increased in HCV
E2-transfected Huh7
SOCS3 is known to be a negative regulator for cytokine
signaling such as interleukin-6, growth hormone, and
interferon-α [30] and also an interfere factor for insulin
signaling by promoting ubiquitin-mediated degradation
of IRS proteins [31,32]. Therefore, the expression levels
of SOCS3 in HCV E2-transfected Huh7 cells were deter-
mined by semi-quantitative RT-PCR and western blot.
Results shown in Figure 3 indicated expression of HCV
E2 led to a dose-dependent increase of SOCS3 expres-
sion at both transcriptional and translational level.
Ubiquitination is involved in the E2-induced reduction of
IRS-1 expression
To investigate the underlying mechanism for E2-induced
reduction of IRS1 expression, E2-transfected cells were
subjected to a treatment with MG132, a proteosomal
proteolysis inhibitor. Results of western blot revealed
that a treatment with MG132 may restore the expression
levels of IRS1 in E2-transfected Huh7 cells (Figure 4A).
Furthermore, immunoprecipitation with anti-IRS-1 and
immunoblotting with anti-ubiquitin antibodies were
conducted to show that the presence of HCV E2 caused
an accumulation of ubiquitin-conjugated IRS-1, as
shown in Figure 4B.
Insulin-induced threonine phosphorylation of akt and
serine phosphorylation of GSK3β is abolished in
E2-transfected Huh7 cells
According to a previous research, IR and IRS-1 protein
expression levels in liver samples from patients with
HCV infection were not altered, while insulin-induced
phosphorylation of IRS-1, PI3K and Akt were impaired
[33]. Therefore, the effect of HCV E2 protein on insulin-
Figure 1 IR and IRS-1 mRNA levels were unchanged with HCV E2 protein expression. Huh7 cells were transfected with FLAG-CMV2 or
FLAG-E2 for 24 hours. After the confirmation of successful E2 expression (A), cells were subjected to semi-quantitative PCR (B) and RT-PCR (C & D)
to show IR and IRS-1mRNA expression levels were not changed by E2 expression. The error bars represented standard deviation from triplicate
experiments. NS means not significant.
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from a time course experiment for condition determin-
ation indicated that Ser473 phosphorylation level of Akt
was increased to 2.5 folds in Huh7 cells underwent an
insulin treatment for 15 minutes, as compared to that of
untreated cells (Figure 5A). A same extent of insulin-
induced increase in Ser473 phosphorylation of Akt wasFigure 2 IR and IRS-1 protein levels while HCV E2 protein expressed i
24 hours and then subjected to western blotting for IR and IRS-1 with β-ac
quantified and the results were shown as histograms mean relative IR (B) a
level of IR was unchanged, that of IRS-1 protein expression was decreased
from triplicate experiments. * indicates p<0.05.seen in FLAG-transfected and E2-transfected Huh7 cells,
indicating that E2 protein has no effect on insulin-induced
Ser473 phosphorylation of Akt. While insulin-induced
Thr308 phosphorylation of Akt is down-regulated in E2-
transfected Huh7 cell suggesting that HCV E2 protein-
induced insulin resistance may occur via a downregulation
of Thr308 phosphorylation of Akt, which may serve as an Huh7. Huh7 cells were transfected with FLAG-CMV2 or FLAG-E2 for
tin acting as internal control (A). Relative photographic density was
nd IRS-1 (C) levels after being normalized by β-actin. While the protein
by HCV E2 expression. The error bars represented standard deviation
Figure 3 HCV E2 induce SOCS3 mRNA and protein levels in
Huh7. Huh7 cells were transfected with FLAG-CMV2 or FLAG-E2 for
24 hours and then subjected to semi-quantitative PCR for SOCS3
expression with GAPDH being an internal control (A). For western
blotting, cell lysate samples were prepared from Huh7 cells
transfected with FLAG-E2 for the indicated time and then subjected
to western blotting for SOCS3 with β-actin and IL-6 treatment
(100 ng/ml for 30 minutes) being an internal control and positive
control, respectively. Results in (B) indicated that the expression
levels of SOCS3 were increased by E2 expression.
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ance (Figure 5B).
It is known that glycogen synthase kinase 3 (GSK3) is
key component of glycogen synthesis that can inhibit the
activity of glycogen synthase (GS). Furthermore, activated
Akt/PKB can induce serine phosphorylation of GSK3
(Ser21 for GSK3α; Ser9 for GSK3β) to inactivate the ki-
nase activity, which subsequently lead to an activation
of GS and then increased glycogen synthesis [34,35].
To assess the influence of HCV E2 protein on insulin-
induced GSK3β phosphorylation. Western blottings were
conducted to show that a 15-minute treatment of insulinFigure 4 HCV E2-caused down-regulation of IRS-1 may be through an
nM), Huh7 cells were transfected with FLAG-CMV2 or FLAG-E2 for 24 hours
(A). Results indicated that MG132, proteosomal proteolysis inhibitor, may re
were subjected to immunoprecipitation with IRS-1 followed by immunoblo
caused an accumulation of ubiquitin-conjugated IRS-1.may induce serine phosphorylation of GSK3β in both un-
transfected and FLAG-transfected Huh7 cells (Figure 5C).
Furthermore, such insulin-induced GSK3β phosphoryl-
ation was inhibited by an expression of E2, as com-
pared to that of untransfected- and FLAG-transfected
Huh7 cells (Figure 5D).
Insulin-induced cellular glucose and glycogen contents
were reduced in response to the expression of E2 protein
To investigate whether HCV E2 protein had the inhibi-
tory ability for insulin-induced cellular glucose uptake,
2-deoxygluose uptake levels were determined. Compared
to that in untransfected and FLAG-transfected Huh7
cells, insulin-induced uptake levels in E2-transfected
Huh7 cells were significantly suppressed by about 66-77
% (Figure 6A). Meanwhile, intracellular glycogen levels
were significantly increased by a 9-hour treatment of in-
sulin, while such enhancement was decreased for about
45% in E2-transfected Huh7 cells, as compared with those
untransfected or FLAG-transfected cells (Figure 6B).
These results suggest that E2 protein can inhibit insulin-
induced cellular glucose uptake and glycogen synthesis.
Discussion
Chronic viral hepatitis, mostly caused by hepatitis B virus
(HBV) or hepatitis C virus (HCV), has been an important
medical global problem with serious consequences in-
cluding cirrhosis and hepatocellular carcinoma. Further-
more, several epidemiological studies suggested that
HCV infection, but not HBV, may contribute the inci-
dence of type 2 diabetes mellitus (T2DM). Patients with
chronic HCV infection had a higher ratio of about 1.8 to
2.5 folds for T2DM, as compared with that of patients
with HBV infection and controls [9-11]. Among multiple
factors involved in the occurrence of T2DM, insulinubiquitination. In the absence or presence of MG132 (10 and 20
and then subjected to immunoblotting with the indicated antibodies
store the E2-related down-regulation of IRS1. Furthermore, cell lysates
tting with anti-ubiquitin antibody. Results in (B) indicated that HCV E2
Figure 5 Insulin-induced phosphorylation of Akt and GSK3β was inhibited by E2 protein. After being transfected with FLAG-CMV2 or
FLAG-E2 for 24 hours and a serum-free incubation 16 hours, cells were subjected to a insulin stimulation for an indicated time period (0, 15, 30
and 60 minutes) followed by western blotting with indicated antibodies to reveal a time-dependent increase of phosphorylation of Akt (A) and
GSK3β (C). Furthermore, transfected or untransfected cells were treated insulin for 30 minutes and then subjected to western blotting to detect
Ser473 and Thr308 phosphorylation of Akt (B) serine phosphorylation of GSK3β (D). Results suggested that an expression of E2 inhibited
insulin-induced Thr308 phosphorylation of Akt and GSK3β phosphorylation.
Hsieh et al. BMC Gastroenterology 2012, 12:74 Page 6 of 8
http://www.biomedcentral.com/1471-230X/12/74resistance is the major one. Therefore, detailed mechan-
isms involved in the relationship between HCV infection
and insulin resistance is worthy to be investigated.
Regarding the involvement of HCV proteins in insulin
resistance, results from intensive studies indicated that
HCV core protein could cause IRS-1 and IRS-2 degrad-
ation through proteasome ubiquitination by inducing
SOCS3 expression, and induce Ser312 phosphorylation
of IRS-1 to impede insulin signaling [20,21]. Furthermore,
study conducted by Pazienza et al. revealed that theFigure 6 Insulin-induced glucose uptake and glycogen synthesis were
transfected with FLAG-CMV2 or FLAG-E2 for 24 hours and a serum-free inc
minutes and then glucose uptake analysis with 2-deoxy-D-[1,2-3 H] glucose
counter and presented as a percentage to that of control (A). For glycogen
before cells were subjected to glycogen assay kit (B). These results clearly i
uptake and glycogen synthesis. The error bars represented standard deviat
p<0.01.mechanism of IRS-1 signaling impairment by HCV core
protein seems to be genotype-specific. For genotype 3a,
core protein causes IRS-1 degradation through SOCS7
upregulation and PPAR-γ downregulation, while in case
of genotype 1b, core protein leads to impaired IRS-1 sig-
naling by activation of mTOR activity [22]. In addition to
core protein, the involvement of other viral proteins
should be investigated. Our previous studies showed that
HCV E2 protein can influence cell apoptosis [27] and fi-
brosis by interfering multiple signaling pathways, andboth decreased by an expression of E2 protein. After being
ubation 16 hours, cells were subjected to insulin stimulation for 13
. [3 H] glucose uptake levels were quantified with liquid scintillation
synthesis analysis, the insulin stimulation was carried out for 9 hours
ndicated that E2 protein can inhibit insulin-induced cellular glucose
ion from triplicate experiments. * indicates p<0.05 and ** indicates
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the insulin signaling pathway. Based on this assumption,
whether HCV E2 protein has the ability of induction of
insulin resistance and relevant molecular mechanisms
were investigated in this study.
With a Huh7 cell line expressing HCV E2 protein, our
results showed that HCV E2 protein can cause IRS-1
protein degradation while the mRNA levels of IR and
IRS-1 were both not altered. Since these two compo-
nents are key components in the upstream of insulin
signaling pathway, such impairment may lead to insulin
resistance [20,28,29]. Previous studies show that HCV
core protein may cause IRS-1 and IRS-2 degradation
through proteasome ubiquitination by inducing SOCS3
expression [20]. Our results also confirmed that HCV
E2 protein can enhance mRNA and protein expression
levels of SOCS3 (Figure 3) and E2-induced IRS-1 down-
regulation was restored by a treatment of MG132. These
results clearly indicated that HCV E2 protein can stimu-
late SOCS3 expression to lead to IRS-1 degradation
though proteasome ubiquitination. Based on other
reports, it was indicated that HCV infection may also
impair the insulin-induced IRS-1, PI3K and Akt phos-
phorylation that lead to insulin resistance [17,33]. Previ-
ous studies shown that phosphorylation of Akt at
Ser473 appears to precede phosphorylation by PDK1 at
Thr308, both sites are separated by 165 amino acids
[36]. Inhibition of Thr308, but not Ser473 phosphoryl-
ation of Akt has been suggested as a basis for decreased
insulin-stimulated glucose transport [37,38]. In a recent
study, it was shown that HCV-induced down-regulation
of GLUT2 expression and up-regulation of gluconeo-
genesis [39]. This suggests that high concentration of
glucose in HCV-infected hepatocytes, although inter-
pretation of their data should be cautioned because they
used a HCV J6/JFH1-infected cells. Likewise, our results
showed that HCV E2 protein can impair insulin-
induced Akt Thr308 phosphorylation (Figure 5B), and
subsequently inhibit glucose uptake (Figure 6A). Other
than an enhancement of glucose uptake, Akt phosphor-
ylation also involves in GSK3-dependent pathway which
responsible for glycogen synthesis and it was reported
that HCV-induced insulin resistance may be through
impairment of insulin-induced GSK3β phosphorylation
[19]. As results shown in figure 5D, such insulin-
induced GSK3β phosphorylation was reversed by an ex-
pression of HCV E2, followed by an inhibition of glyco-
gen synthesis (Figure 6B) and lead to insulin resistance.
Since GSK3 involves in a lot of cellular processes in-
cluding glycogen synthesis, the appearance of increased
GSK3β phosphorylation in Huh7-FLAG without insulin
treatment could be related to cell transfection process,
but not cell starvation before insulin stimulation (data
not shown).Conclusions
Based on abovementioned results, we believe that
decreased IRS-1 expression and induced SOCS3 expression
are involved in HCV E2 protein-induced insulin resistance
through an impairment of Akt/PKB and GSK3β signaling,
which inhibit glucose uptake and glycogen synthesis,
respectively.
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